A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.

Market Analysis and Insights: Global Lower GI Series Market
The global Lower GI Series market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lower GI Series market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lower GI Series market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lower GI Series market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lower GI Series market.

Global Lower GI Series Scope and Market Size
Lower GI Series market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lower GI Series market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Double-Contrast
Single-Contrast

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals